Clinical • PD(L)-1 Biomarker • IO biomarker
|
TP53 (Tumor protein P53) • HRAS (Harvey rat sarcoma viral oncogene homolog)
|
PD-L1 expression • TP53 mutation • PD-L1 overexpression • TP53 wild-type • RAS wild-type • HRAS mutation • TP53 expression • HRAS wild-type
|
PD-L1 IHC 22C3 pharmDx • TruSight Oncology 500 Assay
|
Zarnestra (tipifarnib)